Author Archive for Insider Scoop

Kaman to Acquire Timken Alcor Aerospace Technologies, no terms

Courtesy of Benzinga.

Related KAMN
KeyBanc Prefers These 2 Industrial Names Over The Rest Of The Pack
Earnings Scheduled For February 23, 2015

Kaman Corporation (NYSE: KAMN) announced today that its Aerospace segment has entered into an agreement to acquire Timken Alcor Aerospace Technologies, Inc. (TAAT) of Mesa, Arizona. TAAT designs and supplies aftermarket parts to support businesses conducting maintenance, repair, and overhauls (MROs) in aerospace markets primarily located in North America.

Greg Steiner, President of Kaman Aerospace Group commented, “This is a solid company that nicely complements the aftermarket business of our Specialty Bearings & Engineered Products division. TAAT has demonstrated consistent financial performance and offers engineered products that are adjacent and complementary to Kaman’s current offerings.”

Important factors in Kaman’s decision to acquire TAAT from The Timken Company include organic growth opportunities, the robust quality system, engineering expertise, and strong relationships with engine MROs and fleet operators of both helicopters and fixed wing aircraft. Kaman expects TAAT to achieve further growth through Kaman’s strong sales channels with a global reach.

The organization will become part of Kaman’s Specialty Bearings & Engineered Products division led by Robert Paterson, who commented, “TAAT will be a great fit with our current engineered parts business and has the potential for significant product and market synergies. The operations will remain in Mesa with the current management team and employee base. Global expansion of the product line will be a key focus of our growth strategy for TAAT.”

TAAT has annual sales of approximately $20 million. The transaction is expected to close later this month.

Risks Associated with Forward-Looking Statements

This release includes “forward looking statements” relating to the acquisition discussed above. These statements are based on assumptions currently believed to be valid, but they involve risks and uncertainties that could cause our actual results to differ from those expressed in the forward looking statements. Important uncertainties that could cause our actual results to differ from those expressed in the forward looking statements are identified in our reports filed with the SEC, including our Quarterly Reports on Form 10-Q, our Annual Reports on Form 10-K, and our Current Reports on Form 8-K. The…
continue reading

Vivendi Confirms Raising Telecom Italia Stake to 19.9%

Courtesy of Benzinga.

Related VIVHY
Benzinga's M&A Chatter for Thursday August 7, 2014
EchoStar, GVT End Talks for Brazilian JV

Related TI
Benzinga's Top Downgrades
Mid-Morning Market Update: Markets Edge Lower; Big Lots Earnings Top Views

Vivendi (OTC: VIVHY) announces that it now owns 19.9% of Telecom Italia’s (NYSE: TI) ordinary shares.

The Group became the Italian telecoms operator’s largest shareholder on June 24, 2015 with 14.9% of its ordinary shares. This participation results from a share exchange as part of its exit from the Brazilian telecoms operator GVT for the equivalent of 8.24% of Telecom Italia’s ordinary shares, and from the purchase of shares on the market for 6.66%.

Vivendi has acquired an additional stake through an acquisition of shares on the market and now owns 19.9% of Telecom Italia’s ordinary shares.

The total acquisition price in the consolidated accounts is 3.054 billion euros, i.e. around 1.14 euro per ordinary share.(1)

This new investment confirms Vivendi’s intention to support the telecoms group over the long term and to develop its activities in southern Europe.

Posted-In: News Rumors Insider Trades Press Releases

FBR Met With Juno's Management; Here's What Happened

Courtesy of Benzinga.

Related JUNO
Amgen And Biogen Lead Short Interest Surge In Biotechs
Biotech Expert Talks Potential M&A Activity, Partnerships And Women's Health

  • The share price of Juno Therapeutics, Inc. (NASDAQ: JUNO) has risen 20.41 percent over the past month, touching a high of $43.59 on October 5.
  • Ed White of FBR & Co has maintained an Outperform rating on the company, with a price target of $73.
  • Following investor meetings with the company’s CEO and CFO, White believes that investors might be “unaware of the advancements that Juno is making in lymphoma,” given their focus on leukemia and solid tumors.

According to the FBR report, “Investors’ discussions focused on the company’s products in development for leukemia, lymphoma, and solid tumors but also on the science behind the treatments with questions centering on manufacturing and cell persistence.”

Analyst Ed White believes that Juno Therapeutics differentiates itself from the competition in the way it selects and activates the cells, partly due to the company’s proprietary reagents and attention to the development process.

“The company’s pipeline is deep with 10 candidates potentially in clinical trials using either CAR or TCR by early 2016,” White mentioned, while stating that the data presented by the company was “impressive.”

“First-in-class therapeutic JCAR015 demonstrated encouraging clinical responses in relapsed/refractory acute lymphoblastic leukemia,” White said. BLA for the drug is likely to be filed in late 2016 or early 2017.

In addition, White believes that the solid tumor market, which has garnered investor attention, “could be enormous,” although the timing of the treatments being developed was likely to significantly lag that for liquid tumors.

Latest Ratings for JUNO

Date Firm Action From To
Aug 2015 Standpoint Research Initiates Coverage on Buy
Aug 2015 FBR Capital Initiates Coverage on Outperform
Jul 2015 Northland Securities Initiates Coverage on Outperform

View More Analyst Ratings for JUNO
View the Latest Analyst Ratings

Posted-In: Ed White FBRAnalyst Color Reiteration Analyst Ratings

Top Performing Industries For October 6, 2015

Courtesy of Benzinga.

Related GPL
Worst Performing Industries For July 13, 2015
Worst Performing Industries For July 10, 2015

Related GPRO
Is It Time To Invest In Drones?
Worst Performing Industries For October 5, 2015
The Ambarella Train Might Have Pulled Back Into The Station (Seeking Alpha)

At 10:30 am, the Dow gained 0.08 percent to 16,790.59, the broader Standard & Poor’s 500 index moved down 0.30 percent to 1,981.14 and the NASDAQ composite index fell 0.66 percent to 4,749.94.

The industries that are supporting the market today are:

Silver: This industry jumped 3.7 percent by 10:30 am. The top performer in this industry was Great Panther Silver Ltd(NYSE: GPL), which rose 10.7 percent. Silver futures gained 1.70 percent to trade at $15.98 an ounce.

Photographic Equipment & Supplies: This industry rose 2.2 percent by 10:30 am ET. The top performer in this industry was GoPro Inc (NASDAQ: GPRO), which gained 2.9 percent. GoPro’s PEG ratio is 0.54.

Building Materials Wholesale: This industry moved up 1.6 percent by 10:30 am. The top performer in this industry was Louisiana-Pacific Corporation (NYSE: LPX), which rose 2 percent. Louisiana-Pacific shares have jumped 19.86 percent over the past 52 weeks, while the S&P 500 index has gained 2.68 percent in the same period.

Copper: The industry gained 1.4 percent by 10:30 am. The top performer in this industry was Freeport-McMoRan Inc (NYSE: FCX), which gained 3.8 percent. Freeport-McMoRan has lowered the size of its board and is undertaking a review of strategic alternatives for its oil and gas business.

Posted-In: Top Performing IndustriesNews Intraday Update Markets Movers

Benzinga's Volume Movers

Courtesy of Benzinga.

Related PMCS
Stocks Hitting 52-Week Highs
Morning Market Gainers
Stock Futures Down, Off Lows On News From DuPont, Pepsi, Illumina (Investor’s Business Daily)

Related SWKS
Stocks Hitting 52-Week Highs
Morning Market Gainers
Stock Futures Down, Off Lows On News From DuPont, Pepsi, Illumina (Investor’s Business Daily)

PMC-Sierra Inc (NASDAQ: PMCS) shares climbed 33.22 percent to $10.24. The volume of PMC-Sierra shares traded was 8768 percent higher than normal. PMC-Sierra agreed to be acquired by Skyworks Solutions Inc (NASDAQ: SWKS) for $10.50 per share.

E I Du Pont De Nemours And Co (NYSE: DD) surged 10.82 percent to $56.83. The volume of DuPont shares traded was 665 percent higher than normal. DuPont reported that its CEO Ellen Kullman is stepping down.

Mallinckrodt PLC (NYSE: MNK) shares moved up 4.30 percent to $64.05. The volume of Mallinckrodt traded was 134 percent higher than normal. Mallinckrodt expects fiscal 2016 adjusted earnings of $7.70 to $8.20 per share.

Exterran Holdings, Inc. (NYSE: EXH) shares rose 8.91 percent to $22.50. The volume of Exterran Holdings shares traded was 124 percent higher than normal. Exterran Holdings reported that it has reached financing arrangements to move forward with the planned spin-off of international services and global fabrication businesses through an all secured financing structure.

Posted-In: volume moversNews Intraday Update Markets Movers

IBERIA Adds Basic Energy Services To Conviction List, Removes CLR & PDCE As Analyst Departed Firm

Courtesy of Benzinga.

Related BAS
Basic Energy Cut At Imperial Capital
Benzinga's Top Downgrades

Basic Energy Rated Outperform With A $8.00 PT

Latest Ratings for BAS

Date Firm Action From To
Sep 2015 Imperial Capital Downgrades Outperform In-line
Sep 2015 Macquarie Maintains Underperform
Aug 2015 Wunderlich Upgrades Sell Hold

View More Analyst Ratings for BAS
View the Latest Analyst Ratings

Posted-In: Analyst Color Analyst Ratings

EnerSys Stages Monster Rally After Buyout Rumors Surface

Courtesy of Benzinga.

Related ENS
3 Ways To Bet On The Battery Revolution
Foster Wheeler Arm Wins Power Equipment Deal in Saudi Arabia – Analyst Blog
WSJ: Johnson Controls in talks to buy EnerSys (Seeking Alpha)


EnerSys (NYSE: ENS) rallies from Monday's close ($58.88) to $66.95.
Catalyst is the company may be in talks with Johnson Controls (NYSE: JCI) to be acquired.
Current high is shy of its July 17 high ($67.33).
Was trading in the lower $59's before the rumor surfaced, now at $62.

Posted-In: Technicals Intraday Update Movers Trading Ideas

General Electric Posting Largest Two-Day Gain In Years

Courtesy of Benzinga.

Related GE
Peltz's Purchase Pushes General Electric To Late July Levels
Morning Market Gainers
Cisco Keeps Climbing As It Outlines Future Business (Investor’s Business Daily)

  • General Electric (NYSE: GE) shares rallied from $25.47 to $26.82 on Monday.
  • Catalyst being Nelson Peltz's Triad Fund taking $2.5B stake.
  • After a slightly higher open, immediately bottomed at $26.96 and began to rally.
  • So far, has reached $27.40 and remains near that level.
  • Approaching its June 11 high ($27.64) and June 12 high ($27.48).

Posted-In: Technicals Intraday Update Movers Trading Ideas

Leerink Chats With Biotech Management, Names 20 Stocks To Buy Now

Courtesy of Benzinga.

Leerink Chats With Biotech Management, Names 20 Stocks To Buy Now

  • Leerink recently hosted 24 biopharmaceutical companies at a roundtable event.
  • Of the 24 companies, Leerink now rates 20 of them as Outperform.
  • Many of these 20 companies have strong potential catalysts coming relatively soon.
  • Leerink Partners recently hosted a Rare Disease Roundtable that included fireside chats with 24 biopharmaceutical companies. Following the event, analyst Joseph Schwartz released a report that included a list of 20 Outperform-rated names that attended the roundtable.

    Here’s a list of some of the potential catalysts Schwartz sees for these companies.

    Highlighted Stocks And Catalysts

  • Aegerion Pharmaceuticals, Inc. (NASDAQ: AEGR): The company is guiding conservatively for Juxtapid sales.
  • Agios Pharmaceuticals Inc (NASDAQ: AGIO): The company is seeing clinical benefit in solid tumor indications.
  • Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY): The company reports solid enrollment in APOLLO Ph. III trial and positive OLE Phase II data.
  • Related Link: Morgan Stanley Sees Drug Pricing Still An Overhang For These Names

  • Ascendis Pharma A/S (NASDAQ: ASND): The company is ramping up manufacturing ahead of Ph. III trial in growth deficiency patients.
  • BioMarin Pharmaceutical Inc. (NASDAQ: BMRN): The company has a scheduled PDUFA date of December 27.
  • Cidara Therapeutics Inc (NASDAQ: CDTX): The company is executing well on CD101 development.
  • Dicerna Pharmaceuticals Inc (NASDAQ: DRNA): A decision on the fate of DCR-MYC is expected by the end of 2016.
  • Other Names

    In addition to the specific names mentioned above, Leerink also sees potential upcoming catalysts for the following Outperform-rated names in the space:

    • Auris Medical Holding AG (NASDAQ: EARS)
    • Epizyme Inc (NASDAQ: EPZM)
    • Fate Therapeutics Inc (NASDAQ: FATE)
    • Amicus Therapeutics, Inc. (NASDAQ: FOLD)
    • Insmed Incorporated (NASDAQ: INSM)
    • ProQR Therapeutics NV (NASDAQ: PRQR)
    • Uniqure NV (NASDAQ: QURE)
    • Raptor Pharmaceutical Corp. (NASDAQ: RPTP)
    • Retrophin Inc (NASDAQ: RTRX)
    • SAGE Therapeutics Inc (NASDAQ: SAGE)
    • Acceleron Pharma Inc (NASDAQ: XLRN)
    • Zafgen Inc (NASDAQ: ZFGN)
    • Zogenix, Inc. (NASDAQ: ZGNX)

    Disclosure: The author holds no position in the stocks mentioned.

    Image Credit: Public Domain

    Posted-In: BiopharmaceuticalAnalyst Color Biotech Long Ideas Top Stories Analyst Ratings Trading Ideas General Best of Benzinga

    Dorsey Is Just The Beginning For Twitter's Upside: Bob Peck

    Courtesy of Benzinga.

    Dorsey Is Just The Beginning For Twitter's Upside: Bob Peck

    Related TWTR
    JP Morgan Desk Commentary: Supports Twitter's Choice Of Dorsey As CEO, Expects 'founder element' To Be Added To Ethos & Should Aid In Recruiting Key Talent
    Benzinga's Top Upgrades
    Oil & Gas Issues Boost S&P 500; Twitter, GE Rise (Investor’s Business Daily)

    • Twitter, Inc. (NYSE: TWTR) have declined 46.83 percent over the past six months, from a high of $52.87, reached on April 7.
    • Robert S. Peck of SunTrust Robinson Humphrey has maintained a Buy rating and price target of $38 on the company.
    • Peck believes that naming Jack Dorsey at the permanent CEO, apart from confirming the rest of the leadership team, was the right move by the board and that the management is likely to stabilize going forward.

    Analyst Robert Peck believes that most investors had expected Mr. Dorsey to be names as the permanent CEO. Twitter’s promotion of Adam Bain to COO was also largely anticipated. Although the company did not mention anything about Evan Williams, Anthony Noto is to continue as the CFO.

    “We think the announcements today were the right move by the board and look for the stabilizing of management to be the basis of tangible positive change for the company going forward,” Peck stated.

    Peck expects more changes to take place on the board going forward, as Twitter “looks to supplement skill sets.”

    Although the company did not provide any quarterly update, Mr. Dorsey did mention new product launches that are expected to engage a wider mass audience, while also serving “more deeply engaged users.”

    “We have noticed an increased product launch cadence under Mr. Dorsey in his interim CEO role and would look for this to continue. Importantly, we think this applies to advertising products as well, that can hopefully increase ROIs and ad spending,” Peck added.

    Latest Ratings for TWTR

    Date Firm Action From To
    Oct 2015 Axiom Upgrades Hold Buy
    Oct 2015 Topeka Capital Upgrades Hold Buy
    Oct 2015 Wedbush Assumes Neutral

    View More Analyst Ratings for TWTR
    View the Latest Analyst Ratings

    Posted-In: Analyst Color Long Ideas News Reiteration Management Top Stories Analyst Ratings Movers Best of Benzinga



    China to join Russia in Syria war


    China to join Russia in Syria war By  at Value Walk

    While Russia successfully bombs unidentified targets – either ISIS or U.S.-trained rebels – in Syria, China is planning to join Russia’s own emerging coalition by deploying Shenyang J-15, a carrier-based fighter aircraft.

    Numerous reports have indicated that China is joining Russia’s airstrike campaign in Syria, which has killed at least 39 civilians, including eight children and eight women.


    more from ValueWalk

    Phil's Favorites

    Central Bank Balance Sheets: What Will They Look Like in 2016-2017?

    Courtesy of Mish.

    Reader Gary emailed a link to JP Morgan's Quarterly Market Guide. Here are a pair of charts from page 19 that caught my eye.

    Central Bank Policy Rates

    Current Rates

    • Bank of England: 0.50%
    • Bank of Japan: 0.10%
    • Fed: 0.00%-0.25% (currently 0.14%)
    • ECB: 0.05%
    Central Bank Balance Sheets

    Three ...

    more from Ilene

    Zero Hedge

    Commodity Trading Giants Unleash Liquidity Scramble, Issue Record Amounts Of Secured Debt

    Courtesy of ZeroHedge. View original post here.

    Submitted by Tyler Durden.

    Earlier today, in its latest attempt to restore confidence in its brand and business model after suffering a historic stock price collapse, Glencore - whose CDS recently blew out to a level implying a 50% probability of default - released a 4 page funding worksheet which was meant to serve as a simplied summary of its balance sheet funding obligations and lending arrangements to equity research analysts who have never opened a bond indenture, and which among other things provided a simplied and watered-down estimate of what could happen if and when the company i...

    more from Tyler

    Market News

    News You Can Use From Phil's Stock World


    Financial Markets and Economy

    Here’s how Apple, Nike and others avoided $620 billion in taxes (Market Watch)

    Big U.S. companies are holding more than $2.1 trillion in profits overseas and are avoiding paying about $620 billion in U.S. taxes, according to a study released Tuesday.

    The study by liberal groups Citizens for Tax Justice and the U.S. PIRG Education Fund found that nearly three-quarters of Fortune 500 companies had at least one tax-haven subsidiary in 2014. Bermuda and the Cayman Islands were the most popular tax-haven destinations.


    more from Paul

    Chart School

    Markets Hold Bulk of Gains

    Courtesy of Declan.

    Most of the gains were posted pre-market, but bulls were able to hold gains after a couple of days of bullish strength.

    The S&P is on course to finish with a spinning top doji. The 50-day MA is just overhead and close to 2,000 psychological resistance. Technicals are close to turning net bullish.

    The Nasdaq closed above 20-day MA and has room to run to overhead resistance. Like the S&P, it 's close to turning net bullish technically. Today was a typical consolidation, which given recent price action should be viewed as bullish.


    more from Chart School

    All About Trends

    Mid-Day Update

    Reminder: David is available to chat with Members, comments are found below each post.

    Click here for the full report.

    To learn more, sign up for David's free newsletter and receive the free report from All About Trends - "How To Outperform 90% Of Wall Street With Just $500 A Week." Tell David PSW sent you. - Ilene...

    more from David

    Kimble Charting Solutions

    Germany (DAX)- At critical resistance point, will impact S&P 500

    Courtesy of Chris Kimble.

    In our opinions the German stock market (DAX) is very important on a global scale. We feel its a driving force for many stock markets around the world.

    This leader finds itself at very important price point at this time, which could become a high risk price point.


    The DAX has remained inside of clean rising channel since the 2011 lows. It hit the top of its channel earlier this year, attempting a breakout that failed and a 20%+&#...

    more from Kimble C.S.

    Insider Scoop

    FBR Met With Juno's Management; Here's What Happened

    Courtesy of Benzinga.

    Related JUNO Amgen And Biogen Lead Short Interest Surge In Biotechs Biotech Expert Talks Potential M&A Activity, Partnerships And Women's Health
    • The share price of Juno Therapeutics, Inc. (NASDAQ: JUNO) has risen 20.41 percent over the past month, touching a high of $43.59 on October 5.
    • Ed White of FBR & Co has maintained an Outperform rating on the company, with a pric... more from Insider


    Sector Detector: Searching for solid support in the face of global headwinds

    Reminder: Sabrient is available to chat with Members, comments are found below each post.

    Courtesy of Sabrient Systems and Gradient Analytics

    Uncertainty about the health of the global economy led investors to flee U.S. equities during Q3, primarily driven by worries about China's growth prospects and the Federal Reserve’s decision to not raise rates. Sure, there are plenty of real and perceived headwinds, but on balance it seems that a recession here at home is not in the cards. And when you consider sentiment and the technical picture, it appears that a continuation of Friday’s bounce is in store. The question remains as to whether the seasonally strong Q4 will be able to propel the bulls through levels of resistance that have built up.

    In this weekly update, I give my view o...

    more from Sabrient


    Swing trading portfolio - week of October 5th, 2015

    Reminder: OpTrader is available to chat with Members, comments are found below each post.


    This post is for all our live virtual trade ideas and daily comments. Please click on "comments" below to follow our live discussion. All of our current  trades are listed in the spreadsheet below, with entry price (1/2 in and All in), and exit prices (1/3 out, 2/3 out, and All out).

    We also indicate our stop, which is most of the time the "5 day moving average". All trades, unless indicated, are front-month ATM options. 

    Please feel free to participate in the discussion and ask any questions you might have about this virtual portfolio, by clicking on the "comments" link right below.

    To learn more about the swing trading virtual portfolio (strategy, performance, FAQ, etc.), please click here ...

    more from OpTrader


    Baxter's Spinoff

    Reminder: Pharmboy and Ilene are available to chat with Members, comments are found below each post.

    Baxter Int. (BAX) is splitting off its BioSciences division into a new company called Baxalta. Shares of Baxalta will be given as a tax-free dividend, in the ratio of one to one, to BAX holders on record on June 17, 2015. That means, if you want to receive the Baxalta dividend, you need to buy the stock this week (on or before June 12).

    The Baxalta Spinoff

    By Ilene with Trevor of Lowenthal Capital Partners and Paul Price

    In its recent filing with the SEC, Baxter provides:

    “This information statement is being ...

    more from Pharmboy

    Mapping The Market

    An update on oil proxies

    Courtesy of Jean-Luc Saillard

    Back in December, I wrote a post on my blog where I compared the performances of various ETFs related to the oil industry. I was looking for the best possible proxy to match the moves of oil prices if you didn't want to play with futures. At the time, I concluded that for medium term trades, USO and the leveraged ETFs UCO and SCO were the most promising. Longer term, broader ETFs like OIH and XLE might make better investment if oil prices do recover to more profitable prices since ETF linked to futures like USO, UCO and SCO do suffer from decay. It also seemed that DIG and DUG could be promising if OIH could recover as it should with the price of oil, but that they don't make a good proxy for the price of oil itself. 


    more from M.T.M.


    Watch the Phil Davis Special on Money Talk on BNN TV!

    Kim Parlee interviews Phil on Money Talk. Be sure to watch the replays if you missed the show live on Wednesday night (it was recorded on Monday). As usual, Phil provides an excellent program packed with macro analysis, important lessons and trading ideas. ~ Ilene


    The replay is now available on BNN's website. For the three part series, click on the links below. 

    Part 1 is here (discussing the macro outlook for the markets) Part 2 is here. (discussing our main trading strategies) Part 3 is here. (reviewing our pick of th...

    more from Promotions

    Help One Of Our Own PSW Members

    "Hello PSW Members –

    This is a non-trading topic, but I wanted to post it during trading hours so as many eyes can see it as possible.  Feel free to contact me directly at with any questions.

    Last fall there was some discussion on the PSW board regarding setting up a YouCaring donation page for a PSW member, Shadowfax. Since then, we have been looking into ways to help get him additional medical services and to pay down his medical debts.  After following those leads, we are ready to move ahead with the YouCaring site. (Link is posted below.)  Any help you can give will be greatly appreciated; not only to help aid in his medical bill debt, but to also show what a great community this group is.

    Thank you for you time!

    FeedTheBull - Top Stock market and Finance Sites

    About Phil:

    Philip R. Davis is a founder Phil's Stock World, a stock and options trading site that teaches the art of options trading to newcomers and devises advanced strategies for expert traders...

    Learn more About Phil >>

    As Seen On:

    About Ilene:

    Ilene is editor and affiliate program coordinator for PSW. She manages the site market shadows, archives, more. Contact Ilene to learn about our affiliate and content sharing programs.

    Market Shadows >>